Background
Hepatocellular carcinoma (HCC) is the sixth most common malignant tumor and the second leading cause of cancer-related deaths in the world. 1 The onset of HCC is relatively insidious; in most cases, HCC is diagnosed at advanced stages and is difficult to treat. Presently, surgical resection-based comprehensive treatment is the main treatment for HCC, but with less success rate and high rates of recurrence and metastasis.
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Zhang et al same 660 amino acid residues in the N terminal domain; the main difference between them is the end of the C binding domain, conferring different axonal cargo specificity.
3 KIF1B is located in chromosome region 1p36. 22 and is an important molecule for intracellular vesicle trafficking and organelle transporting. 4, 5 In addition to transport function, KIF1B also plays an important role in tumor suppression by promoting apoptosis. 6 Studies have shown that deficiency of 1p36 region is very common in the individuals with early-onset HCC, but the phenomenon is not observed in individuals with chronic liver disease. It can be speculated that the abnormal chromosomal regions may be associated with the risk of HCC. 7 Through genome-wide association study (GWAS), Zhang et al 8 found a significant association between KIF1B rs17401966 polymorphism and HCC, showing that the polymorphism of the site has a protective effect on HCC. However, a consistent conclusion on the correlation between the gene polymorphism and HCC was not reached, which may be caused by differences in race or ethnicity, as well as the difference in sample size. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Therefore, we carried out a meta-analysis of the whole included case-control studies to make a more accurate estimate of the association.
Methods literature searching strategy
A comprehensive literature searching for all relevant studies published before March 25, 2018 was conducted in PubMed, Web of Science and the Cochrane Library, using the following keywords: KIF1B/Kinesin family member 1B/rs17401966 and locus/mutation/variant*/genotype/polymorphism*/SNP and ([liver/hepatic/hepatocellular/hepato-cellular and carcinom*/ cancer/neoplasm*/malign*/tumor] or HCC or hepatoma*) and the combinations. The relevant bibliographies of identified studies were examined for additional articles. Abstracts and citations were screened by two researchers independently, and any disagreements were resolved by discussing with a third reviewer. The full text of all the eligible articles was reviewed during a second screening. There were no language limitations during the retrieval procedure.
selection and exclusion criteria
All eligible studies included in this meta-analysis met the following inclusion criteria: 1) independent case-control studies performed on humans; 2) evaluated the association between KIF1B (rs17401966) polymorphism and HCC risk; 3) genotype frequencies in case and control groups were available for risk estimate; 4) the diagnosis of the cases was based on pathology; 5) control subjects had no cancer and history of radiotherapy or chemotherapy; and 6) genotype frequencies of the subjects in control groups were in accordance with Hardy-Weinberg equilibrium (HWE). We excluded abstracts, case reports, letters, comments, editorials, reviews, meta-analyses and studies lacking sufficient data. Simultaneously, if the researches were duplicated or shared in more than one study, the most recent publications were included.
Data extraction and synthesis
We used endnote bibliographic software (EndNote X6) to construct an electronic library of citations identified in the literature search. Duplicates were found automatically by endnote and deleted manually. All the extracted data were checked and evaluated twice according to the inclusion criteria listed above by two independent investigators. The following data were extracted from each study: first author, year of publication, country, ethnicity, genotyping method, number of cases and controls, genotype distribution of cases and controls and P-value of HWE in controls. Meanwhile, multicenter studies were divided into several separate studies according to the origin. A third reviewer participated if some disagreements emerged, and a final decision was not made until a consensus was reached.
Quality assessment
The methodological quality assessment was performed based on the modified scoring system used for studies on genetic epidemiological issues. 19 Points were awarded on the basis of representativeness of cases, source of controls, HWE in controls, genotyping examination and association assessment. Total score ranged from 0 (lowest quality) to 8 (highest quality). A study with a score of $6 was classified to be of high quality.
statistical analysis
All statistical analyses were carried out using STATA version 11.0 (StataCorp LP, College Station, TX, USA) and Review Manager version 5.2.0 (The Cochrane Collaboration, 2012). Chi-square test was applied to calculate P-value of HWE in controls, and P.0.05 was considered to be consistent with HWE. 20 The association of KIF1B (rs17401966) 
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KiF1B (rs17401966) polymorphism and hcc susceptibility assess the between-study heterogeneity in this meta-analysis. If there was significant heterogeneity among included studies (P-value of Q-statistic was ,0.1, or I 2 value was .75%), ORs with corresponding 95% CIs were calculated using the random effects model; otherwise, the fixed effects model was selected. 20, 21 The subgroup analysis was conducted based on ethnicity and age (.50 years or #50 years). For studies with Chinese population, we also conducted subgroup analysis by region and environment. Sensitivity analyses were performed to assess the stability of the results. Each study involved in this meta-analysis was deleted each time to reflect the influence of the individual data exerted on the pooled OR. We used Begg's funnel plot and Egger's test (P,0.05 was considered significant) to evaluate the publication bias. 22, 23 All statistical tests were two-sided, and P,0.05 indicated statistical significance.
Results

characteristics of the included studies
The selection process of eligible studies is presented in Figure 1 . A total of 59 relevant articles were preliminarily identified based on our selection strategy. We also identified one article through other sources. 18 Thirty-five articles remained after eliminating duplicated literature. Subsequently, 16 obviously irrelevant articles were excluded unquestionably after reviewing their titles and abstracts. Based on the inclusion and exclusion criteria, eight articles were excluded after reviewing the full text. Finally, 11 studies were eventually included in this meta-analysis. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] The 11 case-control studies were published between 2010 and 2016. Among them, Zhang et al's research consisting of five independent studies was divided into five studies. 8 Similarly, Li et al's and Sawai et al's articles were divided into two and four studies, respectively. 13, 15 Thus, a total of 19 studies from 11 articles with 8,741 cases and 10,812 controls were included in this meta-analysis. A summary of the characteristics of the 19 studies, including first author, year of publication, country, ethnicity, genotyping method, age of cases, number of cases and controls, P-value of HWE and quality score, is shown in Table 1 . Based on quality assessment, all studies were considered to be of high quality (quality scores of these studies were 6-8). 
Meta-analysis results
The genotype distribution and allele frequencies of KIF1B (rs17401966) polymorphism in cases and controls are listed in Table 2 . The main results of our study are shown in Tables 3 and 4 .
As shown in Table 3 and Figure 2 , the pooled results indicated that the association between KIF1B (rs17401966) polymorphism and the decreased occurrence of HCC was 2012  480  35  189  256  484  41  199  244  259  701  281  687  Pan et al   14   2015  376  34  138  204  403  53  167  183  206  546  273  533  sawai et al   15   2012  179  13  61  105  769  45  261  463  87  271  351  1,187  sawai et al   15   2012  142  5  46  91  251  14  91  146  56  228  119  383  sawai et al   15   2012  164  17  59  88  144  15  55  74  93  235  85  203  sawai et al   15   2012  93  10  39  44  187  13  80  94  59  127  106  268  sopipong et al   16   2013  202  21  81  100  196  16  83  97  123  281  115  277  su et al   17   2014  160  24  60  76  160  16  66  78  108  212  98  222  su   18   2015  314  32  153  129  346  26  149  171  217  411  201  491  Zhang et al   8   2010  348  8  100  240  359  26  141  192  116  580  193  525  Zhang et al   8   2010  276  5  86  185  266  24  109  133  96  456  157  375  Zhang et al   8   2010  507  26  181  300  215  21  101  93  233  781  143  287  Zhang et al   8   2010  751  26  228  497  509  35  195  279  280  1,222  265  753  Zhang et al   8   2010  428  12  141  275  440  32  169  239  165  691  233  647 OncoTargets and Figure 4 ). For studies with Chinese population, we also conducted subgroup analysis by region and environment. As shown in Table 4 , when stratified by region (northern China, central China, southern China), we detected an association of the KIF1B (rs17401966) polymorphism with decreased HCC risk in Chinese in southern China based on heterozygote comparison (OR=0.78, 95% CI=0.63-0.98, P=0.03) ( Figure 5 Figure 6) ; however, no statistically significant association was observed in those in coastal areas.
sensitivity analyses
As shown in Table 1 , all the studies were in line with the balance of HWE in control groups. To evaluate the stability of our results, we performed sensitivity analysis to assess 
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Zhang et al the effect of each individual study on the pooled ORs. After excluding each study sequentially, the corresponding ORs were not substantially changed, suggesting that the results of our meta-analysis were stable and reliable.
heterogeneity analysis
Heterogeneity among studies was assessed by Q-statistic. Random effects models were applied if P-value of heterogeneity tests was #0.1 or I 2 was $75% (P#0.1 or I 2 $75%), otherwise, fixed effects models were selected (Tables 3 and 4) .
Publication bias
Begg's test, Egger's test and funnel plot were all used to evaluate the publication bias of the included studies.
No significant publication bias was found in Begg's and Egger's test (P.0.05). Funnel plot also indicated that publication bias did not exist with no obvious asymmetry that could be observed ( Figure 7 ).
Discussion
GWASs have been shown to be unbiased and effective in exploring disease phenotype-associated single-nucleotide polymorphism (SNP). Currently, a large number of GWASs have been reported, most of which are about cancer. 24 Epidemiological and experimental studies have shown that HCC is a complex disease that occurs due to multiple factors, including viral, environmental and genetic factors. With the same environmental background, a small number of people suffer from HCC, whereas others do not, which also shows the importance of genotype. GWASs have found a number of HCC-associated SNPs, such as K1F1B, MICA, HLA-DQA/DQB, SL47W and so on. 12, 13, 25, 26 The existence of genetic etiology of HCC is further confirmed. Identification of HCC susceptibility genes and gene-related molecular mechanisms will provide a theoretical basis for the prevention and clinical diagnosis of HCC and treatment of population at high HCC risk. It is expected to achieve early prevention and individualized treatment of HCC and to improve the therapeutic effect of HCC.
Through GWAS, Zhang et al 8 found a significant association between KIF1B rs17401966 polymorphism and HCC, showing that the polymorphism of the site has a protective effect on HCC. However, a consistent conclusion on the correlation between the gene polymorphism and HCC was not reached. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Hence, we performed this meta-analysis aiming 
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Zhang et al to illuminate the association between KIF1B (rs17401966) polymorphism and HCC. The pooled results of our study indicated that the association was significant. Subgroup analysis stratified by ethnicity showed the same association in Chinese population, but not in non-Chinese. All the above results were consistent with the results of the meta-analysis of Zhang et al 27 and Wang et al. 28 However, the number of included papers in their analysis was less than that in our study. When stratified by age, both old and young patients showed decreased HCC risk, which was consistent with the results of Zhang et al's 27 study. When stratified by region (northern China, central China, southern China), we detected an association between KIF1B (rs17401966) polymorphism and decreased HCC risk in Chinese in southern China.
When stratified by environment (inland areas, coastal areas), we observed the same association in Chinese in Inland areas; however, no statistically significant association was observed in those in coastal areas. It was the first subgroup analysis on Chinese population stratified by region and environment.
Zhang et al 27 also performed subgroup analysis by gender and found that KIF1B rs17401966 polymorphism was significantly associated with HCC in men but not in women. However, the number of papers from which gender data were extracted for their study was only five, and the sample size of women was extremely small. Therefore, we should interpret the results of their study with caution. Zhang et al 27 also performed subgroup analysis based on sample sizes and quality scores and found that rs17401966 polymorphism was 
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KiF1B (rs17401966) polymorphism and hcc susceptibility significantly associated with reduced HCC risk in studies with large sample size and of high quality; however, no significant associations were found in studies with small sample size and of low quality. However, we should realize that small sample sizes and low-quality scores were sources for this heterogeneity, so subgroup analyses stratified by sample sizes and quality scores may not be appropriate. Nevertheless, some limitations of our meta-analysis should be addressed. First, we could not obtain all the raw data of the patients and hence could not conduct subgroup analysis by sex, hepatitis, liver function and other variables. We also failed to clarify gene-gene and gene-environment interactions in the occurrence and development of HCC. Second, only published studies were included in this metaanalysis; however, some unpublished papers may exist and conform to our inclusion criteria. Therefore, publication bias may have appeared, although no statistical evidence was found. Third, our research is only a comprehensive analysis of existing data. We did not verify the association through basic experiments. Moreover, the included papers were mostly based on Chinese population; only four papers were about non-Chinese. Therefore, data from large-scale multicenter studies based on non-Chinese population are still needed to confirm the association between KIF1B (rs17401966) polymorphism and HCC.
Conclusion
Our meta-analysis indicates that KIF1B (rs17401966) polymorphism could decrease HCC risk in Chinese and in overall population, but not in non-Chinese. This association remained significant in Chinese in southern China and inland areas, but not in those in northern or central China and in coastal areas. Further large-scale multicenter studies are warranted to confirm our findings. 
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